{"id":37412,"date":"2016-07-29T08:56:27","date_gmt":"2016-07-29T12:56:27","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=37412"},"modified":"2016-07-29T08:56:27","modified_gmt":"2016-07-29T12:56:27","slug":"pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412","title":{"rendered":"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND)"},"content":{"rendered":"<p><strong>Pfizer Inc. (NYSE:PFE)<\/strong> was the winner of a $40 million bid by <strong>BIND Therapeutics Inc (NASDAQ:BIND)<\/strong>. PFE succeeded at a Section 363 auction initiated by the Cambridge, Massachusetts-based biotechnology company which is selling off its assets. Among other two unidentified companies that had joined the auction Pfizer\u2019s bid was selected as the highest and best. However, the bid is subject to U.S. Bankruptcy Court approval to its acquisition of BIND Therapeutics assets. It is after the court approval that the company will reveal any other additional provisions of its agreement with Pfizer.<\/p>\n<p><strong>Let\u2019s talk about BIND any its collaborations<\/strong><\/p>\n<p>The company is behind the development of novel targeted therapeutics that mainly treats cancer and whose proprietary polymeric nanoparticles is called ACCURINS\u00ae. BIND intends to enlarge ACCURINS\u00ae but with three objectives in mind: &#8211;<\/p>\n<ul>\n<li>Innovation of medicines<\/li>\n<li>Enabling potent pathway inhibitors<\/li>\n<li>Provision of differentiated efficacy with approved drugs<\/li>\n<\/ul>\n<p>The achievement of the above objectives will take the efforts of both through internal research programs and other collaborators. Pfizer is one of the many collaboration partners with BIND, a collaboration that is aiming at developing and commercializing a new class of highly programmable therapeutics. Other collaborations involve Peptidream Inc (TYO:4587), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), AstraZeneca plc (ADR)(NYSE:AZN), Roche Holding Ltd.(VTX:ROG), Merck &amp; Co., Inc.(NYSE:MRK) Macrophage Therapeutics among others.<\/p>\n<p>BIND and AstraZeneca have already described their development of the first nanoparticle preclinical candidate. Putting forward the nanoparticle formulation would solve the inhibitors\u2019 woes that come with cancer attacks. There is no certainty whether Pfizer\u2019s bid to cover liabilities once the likes of severance, fees, and other expenses are factored in the equation. It is also not also known what will happen to BIND which was founded in 2006 by MIT researcher Robert Langer after the sale of its assets.<\/p>\n<p>The bankruptcy came about as a result of an April 26 notice by Hercules Capital, a Palo Alto that was demanding for a $13.2 million balance on its load as well as $1.2 million in fees.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. (NYSE:PFE) was the winner of a $40 million bid by BIND Therapeutics Inc (NASDAQ:BIND). PFE succeeded at a Section 363 auction initiated by [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":34799,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[7028,11296,12001,7544,7545,12004,4504,993,2745,3275,12003,12002],"stock_ticker":[],"class_list":["post-37412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-astrazeneca-plc-adr","tag-astrazeneca-plc-adrnyseazn","tag-bind-therapeutics-inc","tag-bind-therapeutics-inc-nasdaqbind","tag-nasdaqbind","tag-nasdaqsgyp","tag-nyseazn","tag-nysepfe","tag-pfizer-inc-nysepfe","tag-pfizer-inc","tag-synergy-pharmaceuticals-inc","tag-synergy-pharmaceuticals-inc-nasdaqsgyp","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc. (NYSE:PFE) was the winner of a $40 million bid by BIND Therapeutics Inc (NASDAQ:BIND). PFE succeeded at a Section 363 auction initiated by [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-29T12:56:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND)\",\"datePublished\":\"2016-07-29T12:56:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg\",\"keywords\":[\"AstraZeneca plc (ADR)\",\"AstraZeneca plc (ADR)(NYSE:AZN)\",\"BIND Therapeutics Inc\",\"BIND Therapeutics Inc (NASDAQ:BIND)\",\"NASDAQ:BIND\",\"NASDAQ:SGYP\",\"NYSE:AZN\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\",\"Pfizer Inc.\",\"Synergy Pharmaceuticals Inc\",\"Synergy Pharmaceuticals Inc (NASDAQ:SGYP)\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\",\"name\":\"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg\",\"datePublished\":\"2016-07-29T12:56:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412","og_locale":"en_US","og_type":"article","og_title":"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - Wall Street PR","og_description":"Pfizer Inc. (NYSE:PFE) was the winner of a $40 million bid by BIND Therapeutics Inc (NASDAQ:BIND). PFE succeeded at a Section 363 auction initiated by [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2016-07-29T12:56:27+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND)","datePublished":"2016-07-29T12:56:27+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg","keywords":["AstraZeneca plc (ADR)","AstraZeneca plc (ADR)(NYSE:AZN)","BIND Therapeutics Inc","BIND Therapeutics Inc (NASDAQ:BIND)","NASDAQ:BIND","NASDAQ:SGYP","NYSE:AZN","NYSE:PFE","Pfizer Inc (NYSE:PFE)","Pfizer Inc.","Synergy Pharmaceuticals Inc","Synergy Pharmaceuticals Inc (NASDAQ:SGYP)"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412","name":"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg","datePublished":"2016-07-29T12:56:27+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/HEALTH.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nysepfe-wins-a-40-million-bid-by-bind-therapeutics-inc-nasdaqbind-37412#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Inc. (NYSE:PFE) Wins A $40 Million Bid By BIND Therapeutics Inc (NASDAQ:BIND)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=37412"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/34799"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=37412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=37412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=37412"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=37412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}